1. Maternal-Neonatal Dyad Outcomes of Maternal COVID-19 Requiring Extracorporeal Membrane Support: A Case Series.
- Author
-
Douglass, K Marie, Strobel, Katie M, Richley, Michael, Mok, Thalia, de St Maurice, Annabelle, Fajardo, Viviana, Young, Andrew T, Rao, Rashmi, Lee, Lydia, Benharash, Peyman, Chu, Alison, and Afshar, Yalda
- Subjects
Humans ,Pregnancy Complications ,Infectious ,Obesity ,Pregnancy Outcome ,Treatment Outcome ,Respiration ,Artificial ,Critical Care ,Extracorporeal Membrane Oxygenation ,Cesarean Section ,Pregnancy ,Adult ,Infant ,Newborn ,Risk Adjustment ,Female ,Infectious Disease Transmission ,Vertical ,Respiratory Distress Syndrome ,COVID-19 ,SARS-CoV-2 ,COVID-19 Drug Treatment ,Rare Diseases ,Preterm ,Low Birth Weight and Health of the Newborn ,Perinatal Period - Conditions Originating in Perinatal Period ,Infant Mortality ,Pediatric ,Conditions Affecting the Embryonic and Fetal Periods ,Lung ,Management of diseases and conditions ,7.3 Management and decision making ,Reproductive health and childbirth ,Good Health and Well Being ,severe acute respiratory syndrome-coronavirus-2 ,extracorporeal membrane oxygenation ,respiratory distress syndrome ,pregnancy ,Clinical Sciences ,Paediatrics and Reproductive Medicine ,Obstetrics & Reproductive Medicine - Abstract
ObjectiveThis study aimed to describe two cases of acute respiratory distress syndrome (ARDS) secondary to novel coronavirus disease 2019 (COVID-19) in pregnant women requiring extracorporeal membrane oxygenation (ECMO), and resulting in premature delivery.Study designThe clinical course of two women hospitalized with ARDS due to COVID-19 care in our intensive care (ICU) is summarized; both participants provided consent to be included in this case series.ResultsBoth women recovered with no clinical sequelae. Neonatal outcomes were within the realm of expected for prematurity with the exception of coagulopathy. There was no vertical transmission to the neonates.ConclusionThis case series highlights that ECMO is a feasible treatment in the pregnant woman with severe COVID-19 and that delivery can be performed safely on ECMO with no additional risk to the fetus. While ECMO carries its natural risks, it should be considered a viable option during pregnancy and the postpartum period.Key points· COVID-19 may present with a more severe course in pregnancy.. · ECMO may be used in pregnant woman with severe COVID-19.. · Delivery can be performed on ECMO without added fetal risk..
- Published
- 2021